AdventHealth launches first-of-its-kind immunotherapy treatment, clinical trial for specific blood cancer patients

AdventHealth physicians are the first in the world to launch a pioneering treatment targeting certain blood cancers for patients who have exhausted all other types of therapy.
Antigen-Specific T-Cell therapy, which is the subject of a clinical trial at AdventHealth Orlando, uses the immune cells to target cancer cells, and provides what is often the final treatment opportunity for people suffering from certain types of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
The first…Source: http://feedproxy.google.com/~r/ann-en/~3/EUbrDzTcJ5o/